A detailed history of Qube Research & Technologies LTD transactions in Abb Vie Inc. stock. As of the latest transaction made, Qube Research & Technologies LTD holds 1,069,239 shares of ABBV stock, worth $192 Million. This represents 0.32% of its overall portfolio holdings.

Number of Shares
1,069,239
Previous 740,538 44.39%
Holding current value
$192 Million
Previous $127 Million 66.24%
% of portfolio
0.32%
Previous 0.2%

Shares

23 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$163.84 - $199.33 $53.9 Million - $65.5 Million
328,701 Added 44.39%
1,069,239 $211 Million
Q2 2024

Aug 14, 2024

SELL
$154.79 - $180.76 $84.1 Million - $98.2 Million
-543,423 Reduced 42.32%
740,538 $127 Million
Q1 2024

May 14, 2024

BUY
$159.82 - $182.1 $14.3 Million - $16.2 Million
89,165 Added 7.46%
1,283,961 $234 Million
Q4 2023

Feb 13, 2024

BUY
$137.6 - $154.97 $116 Million - $130 Million
841,342 Added 238.03%
1,194,796 $185 Million
Q3 2023

Nov 13, 2023

SELL
$133.59 - $154.65 $74.3 Million - $86 Million
-555,882 Reduced 61.13%
353,454 $52.7 Million
Q2 2023

Aug 14, 2023

BUY
$132.51 - $164.9 $120 Million - $150 Million
909,336 New
909,336 $123 Million
Q4 2022

Feb 14, 2023

BUY
$138.31 - $165.87 $15.8 Million - $19 Million
114,346 Added 2524.19%
118,876 $19.2 Million
Q3 2022

Nov 14, 2022

SELL
$134.21 - $153.93 $3.05 Million - $3.5 Million
-22,708 Reduced 83.37%
4,530 $608,000
Q2 2022

Aug 15, 2022

BUY
$137.62 - $174.96 $2.79 Million - $3.54 Million
20,238 Added 289.11%
27,238 $4.17 Million
Q1 2022

May 09, 2022

BUY
$131.98 - $163.75 $923,859 - $1.15 Million
7,000 New
7,000 $1.14 Million
Q4 2021

Feb 01, 2022

SELL
$107.43 - $135.93 $222,594 - $281,646
-2,072 Closed
0 $0
Q3 2021

Nov 12, 2021

SELL
$106.4 - $120.78 $24.1 Million - $27.4 Million
-226,548 Reduced 99.09%
2,072 $224,000
Q2 2021

Aug 13, 2021

BUY
$105.21 - $117.21 $20.9 Million - $23.3 Million
198,619 Added 662.04%
228,620 $25.8 Million
Q1 2021

May 14, 2021

BUY
$102.3 - $112.62 $3.07 Million - $3.38 Million
30,001 New
30,001 $3.25 Million
Q4 2020

Feb 16, 2021

SELL
$80.49 - $108.67 $23.3 Million - $31.5 Million
-289,815 Closed
0 $0
Q3 2020

Nov 12, 2020

BUY
$85.91 - $100.83 $8.43 Million - $9.89 Million
98,130 Added 51.19%
289,815 $25.4 Million
Q2 2020

Aug 14, 2020

BUY
$73.37 - $98.18 $14.1 Million - $18.8 Million
191,685 New
191,685 $18.8 Million
Q2 2019

Aug 02, 2019

SELL
$65.7 - $83.98 $3.47 Million - $4.44 Million
-52,823 Closed
0 $0
Q1 2019

May 15, 2019

BUY
$77.14 - $90.79 $2.73 Million - $3.21 Million
35,375 Added 202.75%
52,823 $4.26 Million
Q4 2018

Feb 14, 2019

SELL
$77.85 - $96.01 $776,865 - $958,083
-9,979 Reduced 36.38%
17,448 $1.61 Million
Q3 2018

Nov 14, 2018

BUY
$88.91 - $98.84 $1.21 Million - $1.35 Million
13,609 Added 98.49%
27,427 $2.59 Million
Q2 2018

Aug 14, 2018

BUY
$89.78 - $106.23 $974,741 - $1.15 Million
10,857 Added 366.67%
13,818 $1.28 Million
Q1 2018

May 14, 2018

BUY
$92.01 - $123.21 $272,441 - $364,824
2,961 New
2,961 $280,000

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $318B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Qube Research & Technologies LTD Portfolio

Follow Qube Research & Technologies LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Qube Research & Technologies LTD, based on Form 13F filings with the SEC.

News

Stay updated on Qube Research & Technologies LTD with notifications on news.